Skip to main content
Log in

Tramadol Sustained-Release Capsules

A Viewpoint by Sergio Canavero and Vincenzo Bonicalzi

  • Adis Drug Profile
  • Guest Commentary
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Deyo RA, Nachemson A, Mirza SK. Spinal-fusion surgery — the case for restraint. N Engl J Med 2004 Feb 12; 350(7): 722–6

    Article  PubMed  CAS  Google Scholar 

  2. Carragee EJ. Persistent low back pain. N Engl J Med 2005 May 5; 352(18): 1891–8

    Article  PubMed  CAS  Google Scholar 

  3. Bonicalzi V, Canavero S. Intrathecal ziconotide for chronic pain [letter]. JAMA 2004; 292(14): 1681–2

    Article  PubMed  CAS  Google Scholar 

  4. Duhmke RM, Cornblath DD, Hollingshead JR. Tramadol for neuropathic pain. Cochrane Database Syst Rev 2004; (2): CD003726

  5. Canavero S, Bonicalzi V. Chronic neuropathic pain [letter]. N Engl J Med 2003 Jun 26; 348(26): 2688

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Canavero, S., Bonicalzi, V. Tramadol Sustained-Release Capsules. Drugs 66, 232 (2006). https://doi.org/10.2165/00003495-200666020-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-200666020-00009

Navigation